X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5464) 5464
Book Review (1031) 1031
Newsletter (314) 314
Publication (275) 275
Newspaper Article (41) 41
Magazine Article (24) 24
Book Chapter (19) 19
Conference Proceeding (17) 17
Dissertation (3) 3
Reference (3) 3
Book / eBook (1) 1
Trade Publication Article (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4338) 4338
humans (3471) 3471
hyaluronic acid (3071) 3071
female (2065) 2065
male (1694) 1694
hyaluronic acid - administration & dosage (1436) 1436
animals (1417) 1417
middle aged (1307) 1307
surgery (1223) 1223
adult (1020) 1020
hyaluronic acid - adverse effects (1000) 1000
hyaluronic-acid (938) 938
treatment outcome (904) 904
aged (899) 899
hyaluronic acid - therapeutic use (849) 849
osteoarthritis (830) 830
care and treatment (638) 638
dermatology (603) 603
analysis (592) 592
research (531) 531
hyaluronan (501) 501
injections, intra-articular (493) 493
hyaluronic acid - chemistry (460) 460
health aspects (436) 436
pharmacology & pharmacy (433) 433
injections (431) 431
prospective studies (412) 412
medicine & public health (403) 403
orthopedics (374) 374
abridged index medicus (371) 371
efficacy (370) 370
rats (370) 370
knee (365) 365
hyaluronic acid - pharmacology (356) 356
materials science, biomaterials (356) 356
mice (350) 350
sodium hyaluronate (341) 341
pain (337) 337
collagen (336) 336
injection (333) 333
double-blind (331) 331
time factors (331) 331
engineering, biomedical (330) 330
ophthalmology (330) 330
hyaluronic acid - analogs & derivatives (325) 325
drug delivery systems (315) 315
follow-up studies (315) 315
skin (313) 313
rheumatology (303) 303
arthritis (297) 297
nanoparticles (295) 295
cosmetic techniques - adverse effects (287) 287
in-vitro (287) 287
knee osteoarthritis (286) 286
aged, 80 and over (283) 283
cancer (283) 283
hydrogels (283) 283
usage (280) 280
viscosupplementation (269) 269
osteoarthritis, knee - drug therapy (268) 268
safety (266) 266
management (253) 253
drugs (251) 251
cosmetic techniques (250) 250
rejuvenation (247) 247
biocompatible materials - administration & dosage (243) 243
inflammation (241) 241
rabbits (238) 238
acid (236) 236
face (235) 235
tissue engineering (235) 235
prevention (234) 234
therapy (234) 234
biocompatibility (230) 230
acids (227) 227
hyaluronic acid - metabolism (221) 221
tissue adhesions - prevention & control (220) 220
double-blind method (219) 219
clinical trials (217) 217
medical research (214) 214
retrospective studies (214) 214
biocompatible materials - adverse effects (213) 213
stem cells (211) 211
patient satisfaction (210) 210
gels (208) 208
young adult (206) 206
medicine (205) 205
viscosupplements - administration & dosage (205) 205
skin aging - drug effects (203) 203
cartilage (202) 202
urology & nephrology (199) 199
dermal fillers (197) 197
pain measurement (197) 197
hydrogel (196) 196
medicine, research & experimental (194) 194
drug-delivery (192) 192
dentistry (191) 191
disease models, animal (191) 191
complications (185) 185
in-vivo (185) 185
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5638) 5638
French (62) 62
German (57) 57
Spanish (20) 20
Chinese (16) 16
Korean (14) 14
Japanese (11) 11
Polish (11) 11
Portuguese (8) 8
Russian (7) 7
Italian (5) 5
Bulgarian (2) 2
Czech (2) 2
Romanian (2) 2
Swedish (2) 2
Croatian (1) 1
Danish (1) 1
Dutch (1) 1
Hebrew (1) 1
Hungarian (1) 1
Norwegian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 07/2017, Volume 31, Issue 7, pp. 1087 - 1087
Journal Article
Journal Article
European Journal of Obstetrics & Gynecology and Reproductive Biology, ISSN 0301-2115, 2016, Volume 207, pp. 125 - 128
Abstract Objective To assess whether the orally administered combination of hyaluronic acid (HA), chondroitin sulfate (CS), curcumin and quercetin could be... 
Obstetrics and Gynecology | Urinary tract infections | Curcumin | Glycosaminoglycans | Quercetin | Estrogen | MULTICENTER | INTERSTITIAL CYSTITIS | 3-O-BETA-D-GLUCURONIDE | BACTERIAL CYSTITIS | OBSTETRICS & GYNECOLOGY | REPRODUCTIVE BIOLOGY | THERAPY | MICE | METABOLITE | EXPRESSION | Hyaluronic Acid - therapeutic use | Humans | Middle Aged | Secondary Prevention | Urinary Tract Infections - prevention & control | Vaginal Creams, Foams, and Jellies - adverse effects | Estrogens - adverse effects | Urinary Tract Infections - complications | Estrogens - therapeutic use | Vaginal Creams, Foams, and Jellies - therapeutic use | Chondroitin Sulfates - adverse effects | Anti-Infective Agents, Urinary - adverse effects | Aging | Anti-Infective Agents, Urinary - therapeutic use | Postmenopause | Female | Urinary Tract Infections - microbiology | Dietary Supplements - adverse effects | Hyaluronic Acid - adverse effects | Severity of Illness Index | Atrophic Vaginitis - physiopathology | Curcumin - therapeutic use | Quercetin - therapeutic use | Disease Resistance - drug effects | Curcumin - adverse effects | Chondroitin Sulfates - therapeutic use | Combined Modality Therapy - adverse effects | Atrophic Vaginitis - drug therapy | Estrogen Replacement Therapy - adverse effects | Antioxidants - therapeutic use | Estriol - adverse effects | Quercetin - adverse effects | Antioxidants - adverse effects | Estriol - therapeutic use | Urinary Tract Infections - urine | Atrophic Vaginitis - complications | Prevention | Relapse | Postmenopausal women | Sulfates | Hyaluronic acid | Chondroitin | Diseases | Evaluation | Analysis | Index Medicus
Journal Article
BMC Musculoskeletal Disorders, ISSN 1471-2474, 2008, Volume 9, Issue 1, pp. 165 - 165
Background: Symptomatic slow-acting drugs (SYSADOA) have been largely studied over the last decade. The objective of this study is to prepare a document... 
CHONDROITIN SULFATE | OF-RHEUMATOLOGY RECOMMENDATIONS | INTRAARTICULAR HYALURONIC-ACID | EULAR-STANDING-COMMITTEE | TASK-FORCE | GLUCOSAMINE SULFATE | HIP OSTEOARTHRITIS | DOUBLE-BLIND | RHEUMATOLOGY | ORTHOPEDICS | KNEE OSTEOARTHRITIS | AVOCADO/SOYBEAN UNSAPONIFIABLES | Outcome Assessment (Health Care) - methods | Clinical Trials as Topic - statistics & numerical data | Thiophenes - adverse effects | Antirheumatic Agents - administration & dosage | Humans | Anthraquinones - administration & dosage | Thiophenes - administration & dosage | Osteoarthritis - drug therapy | Calcitonin - administration & dosage | Plant Extracts - administration & dosage | Glucosamine - adverse effects | Chondroitin Sulfates - adverse effects | Anthraquinones - adverse effects | Etidronic Acid - adverse effects | Calcitonin - adverse effects | Antirheumatic Agents - adverse effects | Risedronate Sodium | Hyaluronic Acid - adverse effects | Etidronic Acid - analogs & derivatives | Etidronic Acid - administration & dosage | Hyaluronic Acid - administration & dosage | Organometallic Compounds - adverse effects | Glucosamine - administration & dosage | Chondroitin Sulfates - administration & dosage | Organometallic Compounds - administration & dosage | Plant Extracts - adverse effects | Glucosamine | Research | Hyaluronic acid | Drug therapy | Osteoarthritis | Chondroitin | Index Medicus
Journal Article
Nanomedicine: Nanotechnology, Biology, and Medicine, ISSN 1549-9634, 2012, Volume 8, Issue 1, pp. 71 - 80
Abstract The in vivo efficacy of doxorubicin (DOX)-loaded poly(γ-benzyl l -glutamate)- block -hyaluronan (PBLG23 - b -HYA10 )-based polymersomes (PolyDOX) was... 
Internal Medicine | Hyaluronan | Ehrlich ascites tumor (EAT) | Antitumor activity | Doxorubicin | Polymersomes | MEDICINE, RESEARCH & EXPERIMENTAL | BLOCK-COPOLYMERS | SOLID TUMORS | DRUG-DELIVERY | RECEPTOR | NANOSCIENCE & NANOTECHNOLOGY | VASCULAR-PERMEABILITY | CANCER | CARRIERS | PACLITAXEL | LIPOSOMAL DOXORUBICIN | ENDOCYTOSIS HARE | Doxorubicin - blood | Doxorubicin - therapeutic use | Drug Carriers - adverse effects | Hyaluronic Acid - therapeutic use | Nanoparticles - chemistry | Antineoplastic Agents - chemical synthesis | Humans | Drug Carriers - administration & dosage | Polyglutamic Acid - administration & dosage | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Nanoparticles - adverse effects | Drug Carriers - chemistry | Polyglutamic Acid - analogs & derivatives | Antineoplastic Agents - adverse effects | Female | Hyaluronic Acid - blood | Hyaluronic Acid - adverse effects | Doxorubicin - administration & dosage | Endocytosis - immunology | Technetium - chemistry | Rabbits | Hyaluronic Acid - administration & dosage | Hyaluronic Acid - chemistry | Carcinoma, Ehrlich Tumor - drug therapy | Doxorubicin - chemical synthesis | Polyglutamic Acid - blood | Polyglutamic Acid - chemistry | Animals | Hyaluronic Acid - analogs & derivatives | Antineoplastic Agents - blood | Hyaluronan Receptors - immunology | Mice | Mice, Inbred BALB C | Nanoparticles - administration & dosage | Polyglutamic Acid - therapeutic use | Neoplasms, Experimental - drug therapy | Doxorubicin - adverse effects | Polyglutamic Acid - adverse effects | Anthracyclines | Ascites | Hyaluronic acid | Tumors | Index Medicus | Polymers | Chemical Sciences
Journal Article
Ophthalmology, ISSN 0161-6420, 2013, Volume 120, Issue 6, pp. 1158 - 1165
Journal Article
Journal Article